The COVID-19 Pandemic – News and Features

A new observational study aimed at identifying markers that predict how COVID-19 affects patients is being led by clinicians and academics at North Bristol NHS Trust and the University of Bristol.

New research from CSHL scientists suggests that cigarette smoke spurs the lungs to make more ACE2, the protein that the coronavirus responsible for COVID-19 grabs and uses to enter human cells.

A UniSA molecular biologist has teamed up with a leader in artificial intelligence, to help find a compound that could prevent SARS-CoV-2 from infecting human cells.

In this article, we use COVID-19 and cancer to illustrate the range of screening tools at our fingertips today.

New research suggests that eating just one meal high in saturated fat could hinder our ability to concentrate.

Researchers have shown for the first time that an antiviral drug can help speed up the recovery of COVID-19 patients. According to the new study, treatment with interferon(IFN)- α2b may significantly accelerate viral clearance and reduce levels of inflammatory proteins in COVID-19 patients.

UCLA researchers have launched a clinical trial that uses a hormone suppressor commonly used to treat men with prostate cancer to help improve clinical outcomes for men infected with COVID-19.

A team from Columbia University has developed COVID-19 Trial Finder, to help patients, clinicians and healthy volunteers search for appropriate COVID-related clinical trials in their general location.

A robust antiviral T cell response was found in humans with COVID-19 and substantial crossreactivity in unexposed individuals has been detected, providing good news for testing of vaccine candidates.

A specific class of immune cells in the blood induced by vaccination is an earlier indicator of vaccine efficacy than conventional tests for neutralizing antibodies.